Bill > HR1393

This bill amends the Controlled Substances Act to define "currently accepted medical use with severe restrictions" for certain drugs and substances. Specifically, it includes drugs that are active metabolites, moieties, or ingredients of investigational new drugs that have been designated as "breakthrough therapies" or authorized for expanded access to treat serious or life-threatening diseases. The bill also outlines the criteria and authority for the Attorney General to classify such substances, including expedited procedures for moving drugs from Schedule I to Schedule II if they meet the new definition, and a requirement for the Attorney General to move the drug back to Schedule I if it no longer meets the criteria.